Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-9190 + PEG/RIBA in Genotype-1 HCV
NCT00743795Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of tegobuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Oct 2008; status: completed.
02
Drugs
tegobuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00743795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743795.